Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 1, Randomized, ...
Acne is one of the most common skin conditions seen in general practice. Acne vulgaris—the most prevalent form—affects more ...
Discover a study revealing how prebiotics improve acne vulgaris by balancing the skin microbiome and enhancing collagen for ...
Acne vulgaris refers to the pimples, blackheads, or just the “acne” that may break out on your skin. Over-the-counter (OTC) treatments, prescription medication, and lifestyle changes can help manage ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 24, the number of lesions decreased by 53% from ...
The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...
CARLSBAD, Calif. — After Arash Moradzadeh, MD, treated the first 100 consecutive patients in his practice with a 1726-nm laser (AviClear) following its Food and Drug Administration (FDA) clearance for ...
Acne vulgaris remains one of the most pervasive inflammatory skin conditions worldwide, affecting not only adolescents but also adults and contributing to significant psychosocial burden. The ...
More than 50 million people affected by acne in US each year, with market valued at $5.7 billion in 2024 WOBURN, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback